InSightec Ltd. announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the company's ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids. "We are very pleased that the Japanese Ministry of Health has approved the ExAblate system and that women in Japan will now have access to a noninvasive treatment option for uterine fibroids, " said Dr. Kobi Vortman, President and Chief Executive Officer of InSightec. "The approval was based on a growing body of evidence showing that ExAblate is a safe, effective, and durable treatment for this widespread, life-impacting condition.
This new year, make a resolution to improve your health and talk to your doctor about urologic conditions. Although urologic problems may seem embarrassing to talk about, these conditions are more common than you think and a delay in seeking medical attention could cause you unnecessary stress, prolong the problem and even increase your risk for a more serious condition. Experts at the American Urological Association (AUA) and the AUA Foundation recommend talking to your doctor about bladder, prostate or sexual health concerns. Bladder Health Incontinence: Many people are afraid to talk about their incontinence. But, more than 15 million Americans, primarily women, suffer in silence with this condition.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF). Edward Lanphier, Sangamo's president and CEO, will provide an update on the company's ZFP Therapeutic(TM) pipeline and an overview of the company's business strategy and objectives for 2010 during his presentation at the 28th Annual J.P. Morgan Healthcare Conference at 2:30 pm PT, on Wednesday, January 13, 2010.
Being obese could lead to a greater risk of developing the most common form of renal cell cancer, according to research in the January issue of the UK-based urology journal BJUI. US researchers found that obese patients with kidney tumours have 48 per cent higher odds of developing a clear-cell renal cell cancer (RCC) than patients with a body mass index (BMI) of less than 30. And the odds increase by four per cent for every extra BMI point. The team at the Memorial Sloan-Kettering Cancer Center in New York, USA, studied 1, 640 patients with kidney tumours. They found that 88 per cent had malignant tumours and 61 per cent of these were clear-cell RCCs.
In the wake of an earthquake that has devastated this Caribbean country, the U.S. kidney community has mobilized rapidly with the collection of millions of dollars as well as dialysis equipment, medications, supplies and clinical staff to assist in providing life-saving care to Haitian survivors living with kidney failure and in need of emergency treatment. With hospitals and dialysis clinics in Haiti collapsed by the quake, members of Kidney Care Partners (KCP) a coalition of patient advocates, dialysis professionals, care providers and manufacturers dedicated to improving quality of care for individuals with Chronic Kidney Disease are working vigorously to respond to Haiti's pleas for dialysis assistance for this vulnerable population in need of multiple treatments per week to live.
Abnormalities in the kidneys and their blood vessels occur in at least 25% of healthy individuals, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). While most of these conditions are not harmful enough to prevent someone from donating a kidney, future studies are needed to determine their impact on long-term health. When patients undergo computerized tomography (CT) imaging scans for medical reasons, physicians sometimes uncover unexpected abnormal findings in the kidneys or in the arteries that supply blood to the kidneys. To determine how commonly these abnormalities occur in healthy adults who have no clinical illness to justify a CT scan, Elizabeth Lorenz, MD, and Andrew Rule, MD (Mayo Clinic) examined nearly 2000 adults who came in to the Mayo Clinic to see if they could donate a kidney to a patient with kidney failure.